EFPIA - NEWSLETTER

EFPIA Newsletter 31 October 2024

IMAGINE a healthier, more competitive Europe

Watch Lars Fruergaard Jørgensen, CEO of Novo Nordisk and President of EFPIA, as he addresses how to advance health and competitiveness in Portugal and Europe.

Blogs

29 October 2024 Around the world of evidence synthesis (in eighty pages): the methodological and practical...

Application of the European HTA Regulation is around the corner - in only a few months from now, the first products...

28 October 2024 Chasing bold goals to unlock new solutions

Learn more about Timothy Radstake, Vice President and Global Head of Immunology Discovery Research at AbbVie, and his...

Why Clinical Trials are important: Nora's story

Nora was diagnosed with spinal muscular atrophy (SMA) when she was still a baby. At 15, she joined a clinical trial for her own and other kids’ health, at a time when there were no treatments.

Watch Nora’s story and read more about clinical trials in Europe in our report.

Events

07 NOV 2024

Oxford Health Policy Forum - Let's Start Virtual Event

Registration is open for the online policy event "Let's Start", organised by the Oxford Health Policy Forum, which brings...

Learn more →

08 NOV 2024

Health Technology Assessment in Europe, Transformation, Performance? Strasbourg

The aim of this european meeting is to discuss the ongoing implementation and to forecast systemic consequences of the...

Learn more →

EFPIA position on the use of artificial intelligence in the medicinal product lifecycle

AI will have a growing role in the research, development and manufacturing of medicines. To unlock this potential, it is crucial that regulatory frameworks governing the use of AI in the medicine development lifecycle are tailored, fit for purpose, risk-based, non-duplicative, and globally aligned.

Find out more in our paper.

What we are reading

EU lagging US and China on clinical trials - report 30 October 2024 (Euronews)

HCPs rank pharma in top sectors for trust, says Ipsos 21 October 2024 (EMJ)

Recommendations for the EU Life sciences Strategy 01 October 2024 (Nordic Pharma Associations)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶